Salvatore Novo
Salvatore Novo
Professore Ordinario di Cardiologia, Università degli Studi di Palermo
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on …
Authors/Task Force Members, MF Piepoli, AW Hoes, S Agewall, C Albus, ...
European journal of preventive cardiology 23 (11), NP1-NP96, 2016
2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS) Document covering …
V Aboyans, JB Ricco, MLEL Bartelink, M Björck, M Brodmann, T Cohnert, ...
European heart journal 39 (9), 763-816, 2018
Comparison of the genomes of two Xanthomonas pathogens with differing host specificities
ACR da Silva, JA Ferro, FC Reinach, CS Farah, LR Furlan, RB Quaggio, ...
Nature 417 (6887), 459-463, 2002
Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis
S Schulman, AK Kakkar, SZ Goldhaber, S Schellong, H Eriksson, ...
Circulation 129 (7), 764-772, 2014
Nutraceuticals and dyslipidaemia: beyond the common therapeutics
P Scicchitano, M Cameli, M Maiello, PA Modesti, ML Muiesan, S Novo, ...
Journal of Functional Foods 6, 11-32, 2014
An update on the role of markers of inflammation in atherosclerosis
E Corrado, M Rizzo, G Coppola, K Fattouch, G Novo, I Marturana, ...
Journal of atherosclerosis and thrombosis, 0912220131-0912220131, 2009
The changing landscape for stroke prevention in AF: findings from the GLORIA-AF registry phase 2
MV Huisman, KJ Rothman, M Paquette, C Teutsch, HC Diener, SJ Dubner, ...
Journal of the American College of Cardiology 69 (7), 777-785, 2017
Markers of inflammation and infection influence the outcome of patients with baseline asymptomatic carotid lesions: a 5-year follow-up study
E Corrado, M Rizzo, R Tantillo, I Muratori, F Bonura, G Vitale, S Novo
Stroke 37 (2), 482-486, 2006
Moderate alcohol use and health: a consensus document
A Poli, F Marangoni, A Avogaro, G Barba, S Bellentani, M Bucci, ...
Nutrition, Metabolism and Cardiovascular Diseases 23 (6), 487-504, 2013
Critical limb ischemia: definition and natural history
S Novo, G Coppola, G Milio
Current Drug Targets-Cardiovascular & Hematological Disorders 4 (3), 219-225, 2004
Cardiovascular risk assessment beyond systemic coronary risk estimation: a role for organ damage markers
M Volpe, A Battistoni, G Tocci, EA Rosei, AL Catapano, R Coppo, ...
Journal of hypertension 30 (6), 1056-1064, 2012
Classification, epidemiology, risk factors, and natural history of peripheral arterial disease
S Novo
Diabetes, Obesity and Metabolism 4, S1-S6, 2002
Carotid atherosclerosis and chronic hepatitis C: a prospective study of risk associations
S Petta, D Torres, G Fazio, C Camma, D Cabibi, V Di Marco, A Licata, ...
Hepatology 55 (5), 1317-1323, 2012
Non-coronary atherosclerosis
A Gallino, V Aboyans, C Diehm, F Cosentino, H Stricker, E Falk, ...
European heart journal 35 (17), 1112-1119, 2014
Alirocumab reduces total nonfatal cardiovascular and fatal events: the ODYSSEY OUTCOMES trial
M Szarek, HD White, GG Schwartz, M Alings, DL Bhatt, VA Bittner, ...
Journal of the American College of Cardiology 73 (4), 387-396, 2019
Influence of climatic variables on acute myocardial infarction hospital admissions
MG Abrignani, S Corrao, GB Biondo, N Renda, A Braschi, G Novo, ...
International journal of cardiology 137 (2), 123-129, 2009
Detection of left ventricular systolic dysfunction in cardiac amyloidosis with strain rate echocardiography
D Bellavia, TP Abraham, PA Pellikka, GB Al-Zahrani, A Dispenzieri, JK Oh, ...
Journal of the American Society of Echocardiography 20 (10), 1194-1202, 2007
Impact of moderate ischemic mitral regurgitation after isolated coronary artery bypass grafting
K Fattouch, R Sampognaro, G Speziale, M Salardino, G Novo, M Caruso, ...
The Annals of thoracic surgery 90 (4), 1187-1194, 2010
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY …
KK Ray, HM Colhoun, M Szarek, M Baccara-Dinet, DL Bhatt, VA Bittner, ...
The lancet Diabetes & endocrinology 7 (8), 618-628, 2019
Double-blind, crossover study of the clinical efficacy and the hemorheological effects of pentoxifylline in patients with occlusive arterial disease of the lower limbs
A Strano, G Davi, G Avellone, S Novo, A Pinto
Angiology 35 (7), 459-466, 1984
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20